logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

(Ebook) Handbook of Anticancer Pharmacokinetics and Pharmacodynamics (Cancer Drug Discovery and Development) by William D. Figg, Howard L. McLeod ISBN 1588291774

  • SKU: EBN-2534524
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

4.6

6 reviews
Instant download (eBook) Handbook of Anticancer Pharmacokinetics and Pharmacodynamics (Cancer Drug Discovery and Development) after payment.
Authors:William D. Figg, Howard L. McLeod
Pages:643 pages.
Year:2004
Editon:Cancer Drug Discovery and Development
Publisher:Humana Press
Language:english
File Size:10.17 MB
Format:pdf
ISBNS:1588291774
Categories: Ebooks

Product desciption

(Ebook) Handbook of Anticancer Pharmacokinetics and Pharmacodynamics (Cancer Drug Discovery and Development) by William D. Figg, Howard L. McLeod ISBN 1588291774

Leading investigators synthesize the entire laboratory and clinical process of developing anticancer drugs to create a single indispensable reference that covers all the steps from the identification of cancer-specific targets to phase III clinical trials. These expert authors provide their best guidance on a wide variety of issues, including clinical trial design, preclinical screening, and the development and validation of bioanalytic methods. The chapters on identifying agents to test in phase III trials and on trial design for the approval of new anticancer agents offer a unique roadmap for moving an agent to NDA submission.
*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products